2010 DePuy Hip Recall

Last updated

The 2010 DePuy Hip Replacement Recall was instituted when DePuy Orthopaedics, Inc., a division of Johnson & Johnson, recalled its ASR XL Acetabular metal-on-metal hip replacement system on August 24, 2010. [1] [2]

Contents

Background

The recall came after data from a study indicated that the five year failure rate of this product is approximately 13%, or 1 in 8 patients. [3] Even if the defective device is replaced, it can leave behind dangerous, possibly deadly fragments that may not be discovered for years. DePuy identified reasons for the failure of the hip replacement system as component loosening, component malalignment, infection, fracture of the bone, dislocation, metal sensitivity and pain. Additional complications from the hip replacement system may include increased metal ion levels in the blood, bone staining, necrosis, swelling, nerve damage, tissue damage and/or muscle damage.[ citation needed ][ medical citation needed ]

At the beginning of 2011, DePuy Orthopaedics said they were phasing out the ASR Hip Implant because of declining sales, but never mentioned the high failure rate data from an Australian implant registry. In March 2011, The New York Times reported that DePuy issued its first warning to doctors and patients about the high early failure rate. [1] However, at this point, they still had not issued a recall of the product. In fact, they claimed any statements referencing a recall were false. [4]

Lawsuits

About 93,000 persons worldwide received an ASR implant. [5]

Shine Lawyers commenced an Australian class action in the Federal Court of Australia on September 27, 2011, against DePuy International Pty Ltd and Johnson and Johnson Medical Pty Ltd. Both lawsuits claimed that the DePuy ASR hip replacement was defectively designed, that DePuy knew that there were problems with the implant early on but did not do anything to let patients or their surgeons know about the possible problems.[ citation needed ]

United States

The first lawsuit in the United States against DePuy Orthopaedics was filed on June 15, 2010.[ citation needed ]

Through the multidistrict litigation process, the cases were centralized in different courts depending on the exact implant at issue. The United States Judicial Panel on Multidistrict Litigation (JPML) issued a ruling on December 7, 2010 [6] that determined the fate of the United States lawsuits relating to the ASR XL Acetabular Hip System implants. Its ruling stated that all cases filed across the country "are transferred to the Northern District of Ohio and, with the consent of that court, assigned to the Honorable David A. Katz for coordinated or consolidated pretrial proceedings." On January 26, 2011, Judge Katz entered an order in the multidistrict litigation naming the leadership counsel for both the plaintiffs and the defendants. Ben Gordon, Eric Kennedy, Ellen Relkin, Mark Robinson, Christopher Seeger, and Steven Skikos were named on the plaintiffs' Executive Committee. Robert Tucker and Susan Sharko were named as defendants' Co-Lead Counsel. [ citation needed ]

In 2013, Johnson & Johnson announced that it would pay $2.5 billion to settle claims related to the ASR XL implants globally. Johnson & Johnson retained an option to withdraw the settlement if too few claimants signed up, but in May 2014 it announced it would not withdraw the global settlement. Settlements began at a base of $250,000. Johnson & Johnson continued to deny culpability. [7]

Pinnacle implant litigation

On May 24, 2011, the JPML centralized all cases relating to the Pinnacle Acetabular Cup System in the Northern District of Texas before judge James E. Kinkeade. [8]

The Pinnacle litigation centralized in the Northern District of Texas proceeded to a series of bellwether trials for selected plaintiffs from different states. In a first trial with a single Montana plaintiff, the jury found for DePuy. [9] In a second trial with five Texas plaintiffs, the jury awarded $502 million to the plaintiffs, consisting of $142 million in actual damages and $360 million in punitive damages. [10] The judge reduced this to a total judgment of $151 million based on the Texas limitation on punitive damages. [11] In a third trial with six California plaintiffs, the jury awarded $1.04 billion to the plaintiffs, consisting of $30 million in actual damages and over $1 billion in punitive damages. [12]

India

Of the total number of people receiving the implants, about 4,700 were in India. As of 2018, J&J committed to working with the Indian government to support all Indian ASR patients. In late 2018, an Indian government report, the accuracy of which has been disputed by J&J, proposed that each patient who had a faulty implant should receive a lump sum payment of ₹2 million (US$27,812). J&J had previously provided US$2.25 million to cover diagnostic and surgical costs to patients with defective implants, but the Indian government was concerned that these monies included no compensatory funds. [5]

Related Research Articles

<span class="mw-page-title-main">Johnson & Johnson</span> American multinational pharmaceutical and consumer goods corporation

Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the largest United States corporations. In 2023, the company was ranked 40th in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 130,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato.

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.

<span class="mw-page-title-main">Hip replacement</span> Surgery replacing hip joint with prosthetic implant

Hip replacement is a surgical procedure in which the hip joint is replaced by a prosthetic implant, that is, a hip prosthesis. Hip replacement surgery can be performed as a total replacement or a hemi/semi(half) replacement. Such joint replacement orthopaedic surgery is generally conducted to relieve arthritis pain or in some hip fractures. A total hip replacement consists of replacing both the acetabulum and the femoral head while hemiarthroplasty generally only replaces the femoral head. Hip replacement is one of the most common orthopaedic operations, though patient satisfaction varies widely between different techniques and implants. Approximately 58% of total hip replacements are estimated to last 25 years. The average cost of a total hip replacement in 2012 was $40,364 in the United States, and about $7,700 to $12,000 in most European countries.

Arthroplasty is an orthopedic surgical procedure where the articular surface of a musculoskeletal joint is replaced, remodeled, or realigned by osteotomy or some other procedure. It is an elective procedure that is done to relieve pain and restore function to the joint after damage by arthritis or some other type of trauma.

DePuy Synthes is a franchise of orthopaedic and neurosurgery companies. Acquired by Johnson & Johnson in 1998, its companies form part of the Johnson & Johnson Medical Devices group. DePuy develops and markets products under the Codman, DePuy Mitek, DePuy Orthopaedics and DePuy Spine brands.

In United States law, multidistrict litigation (MDL) refers to a special federal legal procedure designed to speed the process for handling complex cases with numerous plaintiffs making similar claims, such as air disaster litigation or complex product liability suits.

<span class="mw-page-title-main">Hip resurfacing</span>

Hip resurfacing has been developed as a surgical alternative to total hip replacement (THR). The procedure consists of placing a cap, which is hollow and shaped like a mushroom, over the head of the femur while a matching metal cup is placed in the acetabulum, replacing the articulating surfaces of the person's hip joint and removing very little bone compared to a THR. When the person moves the hip, the movement of the joint induces synovial fluid to flow between the hard metal bearing surfaces lubricating them when the components are placed in the correct position. The surgeon's level of experience with hip resurfacing is most important; therefore, the selection of the right surgeon is crucial for a successful outcome. Health-related quality of life measures are markedly improved and the person's satisfaction is favorable after hip resurfacing arthroplasty.

Mikal Watts is an American attorney from San Antonio, Texas and a prolific donor to the Texas and national Democratic Party, and candidates running for office as Democrats. He formed an exploratory committee to run for Senator of Texas against incumbent John Cornyn in the 2008 U.S. Senate elections, but announced on October 23, 2007 his decision not to run.

<span class="mw-page-title-main">W. Mark Lanier</span> American lawyer (born 1960)

William Mark Lanier is an American trial lawyer and founder and CEO of the Lanier Law Firm. He has led a number of high-profile product litigation suits resulting in billions of dollars in damages, including Johnson & Johnson baby powder and Merck & Co.'s Vioxx drug.

Minimally invasive hip resurfacing (MIS) is a total or partial hip surgery that can be carried out through an incision of less than 10 cm without imparting great forces on the anatomy or compromising component positioning.

<span class="mw-page-title-main">Bard (company)</span> Pharmaceutical company

C. R. Bard, Inc., headquartered in Murray Hill, New Jersey, USA, was a developer, manufacturer, and marketer of medical technologies in the vascular medicine, urology, oncology, and surgical specialty fields. C. R. Bard marketed its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. An S&P 500 company with approximately 14,000 employees in 2015, Bard is perhaps best known for having introduced the Foley catheter in 1934.

Edward F. Blizzard is a pharmaceutical injury attorney and a founding partner of Blizzard Greenberg, PLLC based in Houston, Texas.

<i>Deepwater Horizon</i> litigation Aspect of the Deepwater Horizon explosion

The civil and criminal proceedings stemming from the explosion of Deepwater Horizon and the resulting massive oil spill in the Gulf of Mexico began shortly after the April 20, 2010 incident and have continued since then. They have included an extensive claims settlement process for a guilty plea to criminal charges by BP, and an ongoing Clean Water Act lawsuit brought by the U.S. Department of Justice and other parties.

"Professor" Derek McMinn is a British orthopaedic surgeon and inventor who practised in Birmingham, United Kingdom at the BMI Edgbaston Hospital until his suspension in 2020. McMinn is currently under police investigation for allegedly keeping the body parts of thousands of patients over a 25-year period.

Metallosis is the medical condition involving deposition and build-up of metal debris in the soft tissues of the body.

<span class="mw-page-title-main">Hip arthroscopy</span>

Hip arthroscopy refers to the viewing of the interior of the acetabulofemoral (hip) joint through an arthroscope and the treatment of hip pathology through a minimally invasive approach. This technique is sometimes used to help in the treatment of various joint disorders and has gained popularity because of the small incisions used and shorter recovery times when compared with conventional surgical techniques. Hip arthroscopy was not feasible until recently, new technology in both the tools used and the ability to distract the hip joint has led to a recent surge in the ability to do hip arthroscopy and the popularity of it.

Implant failure refers to the failure of any medical implant to meet the claims of its manufacturer or the health care provider involved in its installation. Implant failure can have any number of causes. The rates of failure vary for different implants.

<span class="mw-page-title-main">Shine Lawyers</span> Australian legal firm specialising in personal injury compensation

Shine Lawyers is an Australian law firm specialising in personal injury compensation law, operating on a no win no fee basis. The firm has expanded into providing toxic exposure, silica and dust disease, abuse and medical negligence services through a number of acquisitions.

<span class="mw-page-title-main">William H. Harris (orthopaedic surgeon)</span> American orthopaedic surgeon

William H. Harris, is an American orthopaedic surgeon, Founder and Director Emeritus of the Massachusetts General Hospital Harris Orthopaedics Laboratory, and creator of the Advances in Arthroplasty course held annually since 1970.

<span class="mw-page-title-main">Christopher A. Seeger</span> New York attorney (born 1960)

Christopher A. Seeger is an American lawyer who specializes in multidistrict mass tort and class action litigation. He received the most multidistrict litigation (MDL) appointments of any lawyer between 2016 and 2019 according to a 2020 ALM study. Seeger is a founding partner of the firm Seeger Weiss LLP.

References

  1. 1 2 Barry Meier (March 9, 2010). "With Warning, a Hip Device Is Withdrawn". The New York Times . Retrieved 2010-12-17. A unit of Johnson & Johnson, just months after saying it was phasing out an artificial hip implant because of slowing sales, has warned doctors that the device appears to have a high early failure rate in some patients.
  2. ↑ Barry Meier (December 15, 2010). "The Implants Loophole". The New York Times . Retrieved 2010-12-17. A recently recalled artificial hip made by a unit of Johnson & Johnson, designed to last 15 years or more, is failing worldwide at unusually high rates after just a few years.
  3. ↑ Farrell, Greg (9 March 2011). "J&J Hip Failure Rate as High as 49 Percent, U.K. Doctors Say". Bloomberg.com. Bloomberg. Retrieved 24 February 2012.
  4. ↑ "Re: DuPay ASR Hip Cup (Cease and Desist Letter)". Kramer Levin Naftalis & Frankel LLP. April 1, 2010. Retrieved 12 November 2013.
  5. 1 2 Kalra, Aditya (7 September 2018). "J&J to work with India on compensation for recalled hip implants". Reuters. Retrieved 8 September 2018.
  6. ↑ Hansen, David. "IN RE: DePUY ORTHOPAEDICS, INC., ASR HIP IMPLANT PRODUCTS LIABILITY LITIGATION" (PDF). Panel on Multidistrict Litigation. Archived from the original (PDF) on 2011-07-21. Retrieved 2011-03-04.
  7. ↑ Saunders, Joseph (June 1, 2014). "DePuy ASR Total Hip Replacement Settlement Update". Saunders & Walker, P.A. Retrieved July 17, 2014.
  8. ↑ John G. Heyburn II (May 24, 2011). "Transfer Order" (PDF). United States Judicial Panel on Multidistrict Litigation.
  9. ↑ Jef Feeley (2014-10-23). "Johnson & Johnson Wins First Pinnacle Hip Implant Trial". Bloomberg News. Archived from the original on 2016-06-25.
  10. ↑ Tom Korosec; Jef Feeley (March 17, 2016). "J&J Ordered to Pay $502 Million Over Pinnacle Hip Failures". Archived from the original on 2016-07-09.
  11. ↑ Erica Teichert (December 1, 2016). "Johnson & Johnson hit with over $1 billion verdict on hip implants". Reuters.com.
  12. ↑ Jef Feeley; Tom Korosec (2016-12-01). "J&J; Ordered to Pay Record $1 Billion for Faulty Hip Implants". Archived from the original on 2016-12-02.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.